213 related articles for article (PubMed ID: 35610648)
1. Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis.
Ng CW; Wong KK
J Ovarian Res; 2022 May; 15(1):63. PubMed ID: 35610648
[TBL] [Abstract][Full Text] [Related]
2. The prognostic values of estrogen receptor alpha and beta in patients with gastroesophageal cancer: A meta-analysis.
Zhang D; Ku J; Yi Y; Zhang J; Liu R; Tang N
Medicine (Baltimore); 2019 Nov; 98(46):e17954. PubMed ID: 31725654
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
Tan W; Li Q; Chen K; Su F; Song E; Gong C
Oncotarget; 2016 Mar; 7(9):10373-85. PubMed ID: 26863572
[TBL] [Abstract][Full Text] [Related]
4. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
[TBL] [Abstract][Full Text] [Related]
8. Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis.
Shen Z; Luo H; Li S; Sheng B; Zhao M; Zhu H; Zhu X
Oncotarget; 2017 Sep; 8(37):62400-62413. PubMed ID: 28977954
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to quantify estradiol-induced loss of ERβ1 protein in older mouse ovarian surface epithelium: new tools to assess the role of ER protein subtypes in predisposing to ovarian epithelial cancer?
Gulliver LS; Hurst PR
Horm Cancer; 2011 Aug; 2(4):204-13. PubMed ID: 21773845
[TBL] [Abstract][Full Text] [Related]
10. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis.
Meng W; Liao Y; Chen J; Wang Y; Meng Y; Li K; Xiao H
J Thorac Dis; 2021 Jul; 13(7):4281-4300. PubMed ID: 34422356
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
Sehouli J; Braicu EI; Richter R; Denkert C; Jank P; Jurmeister PS; Kunze CA; Budczies J; Darb-Esfahani S; Schmitt WD; Traut A; Grabowski J; Taube ET; Plett H
Hum Pathol; 2019 Mar; 85():299-308. PubMed ID: 30428389
[TBL] [Abstract][Full Text] [Related]
13. Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
Bernardo C; Monteiro FL; Direito I; Amado F; Afreixo V; Santos LL; Helguero LA
Front Endocrinol (Lausanne); 2021; 12():684140. PubMed ID: 34690921
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis.
Shi M; Mu Y; Zhang H; Liu M; Wan J; Qin X; Li C
Medicine (Baltimore); 2018 Aug; 97(32):e11505. PubMed ID: 30095616
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptors as a marker of poor survival in epithelial ovarian cancer.
van Kruchten M; van der Marel P; de Munck L; Hollema H; Arts H; Timmer-Bosscha H; de Vries E; Hospers G; Reyners A
Gynecol Oncol; 2015 Sep; 138(3):634-9. PubMed ID: 26115976
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma.
Guntupalli SR; Cao D; Shroff R; Gao F; Menias C; Stewart Massad L; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2013 Jul; 20(7):2373-9. PubMed ID: 23344579
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.
Schade GR; Holt SK; Zhang X; Song D; Wright JL; Zhao S; Kolb S; Lam HM; Levin L; Leung YK; Ho SM; Stanford JL
J Urol; 2016 Jun; 195(6):1760-6. PubMed ID: 26804755
[TBL] [Abstract][Full Text] [Related]
18. Association of H3K9me3 with breast cancer prognosis by estrogen receptor status.
Zhou M; Yan JQ; Chen QX; Yang YZ; Li YL; Ren YX; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
Clin Epigenetics; 2022 Oct; 14(1):135. PubMed ID: 36303253
[TBL] [Abstract][Full Text] [Related]
19. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis.
Xu K; Yang S; Zhao Y
Oncotarget; 2017 Jan; 8(1):285-302. PubMed ID: 27690218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
